Pain News and Research

Latest Pain News and Research

Children with sickle cell disease who are at risk for a stroke need ongoing blood transfusions to reduce their risk

“This important study shows the value of continuing periodic blood transfusions in preventing the serious and debilitating consequences of stroke,” says NHLBI Acting Director Barbara Alving. “At the same time, there are risks of chronic transfusions and the decision to continue with this treatment must be made on a case-by-case basis.”

6 Dec 2004

Single dose phase I data on CG53135 for the prevention of oral mucositis

CuraGen Corporation has announced results presented from a Phase I clinical trial with CG53135 for the prevention of oral mucositis (OM) in patients receiving high dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (AHSCT) at the ASH 46th Annual Meeting in San Diego, CA.

5 Dec 2004

Botox may reduce the incidence of keloids, improving the appearance of scars

Can a modern-day drug cure an age-old healing disorder that causes more harm than the actual injury?

4 Dec 2004

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

Sildenafil is the active ingredient in Viagra, Pfizer's erectile dysfunction medication used by more than 23 million men worldwide.

4 Dec 2004

A decade of neglect has weakened UNICEF and threatened the future of child survival

As a high-level forum assessing the progress on global health in relation to the millennium development goals concludes its meeting in Abuja, Nigeria, today, the rhetoric of success repeated by those charged with ending the needless deaths of millions of the world's children masks their own deep-seated failure to grapple with critical institutional weaknesses in their own ranks.

4 Dec 2004

Method for healing spinal injuries in dogs offers hope for preventing human paralysis

Lab tests have shown that an injection of a liquid polymer known as polyethylene glycol (PEG), if administered within 72 hours of serious spinal injury, can prevent most dogs from suffering permanent spinal damage.

3 Dec 2004

New method measures emotional quality of daily experience

For Marcel Proust, the taste of a madeleine conjured remembrance of the distant past. In today's multi-tasking, hyper-speed world, it can be a trick to remember what we did yesterday.

2 Dec 2004

$3 million to research whether stress-management techniques can improve immune system responses in women with breast cancer

The National Institutes of Health has awarded the Virginia Commonwealth University School of Nursing a $3 million grant to research whether stress-management techniques can improve immune system responses in women with breast cancer.

2 Dec 2004

Potential vaccine for the deadly toxin ricin

A potential vaccine for the deadly toxin ricin, a "Category B" biological agent, will enter the first phase of clinical testing in coming weeks at UT Southwestern Medical Center at Dallas.

30 Nov 2004

African-Americans and the poor with work-related back injuries clearly fare worse

African-Americans with work-related back injuries have less money spent on their medical care and receive less compensation for their injuries than Caucasians, according to a Saint Louis University study in the December issue of Pain.

30 Nov 2004

Botox reduces pain and spasms during breast reconstruction after mastectomy

Botox, known for reducing wrinkles, also can be used to reduce pain and spasms during breast reconstruction after mastectomy, according to results of a recent University of Arkansas for Medical Sciences (UAMS) study.

29 Nov 2004

Spinal manipulation combined with exercise program offers effective treatment for back pain

The American Chiropractic Association (ACA) is applauding a new study from the Medical Research Council (MRC) that shows that spinal manipulation – the primary form of care performed by doctors of chiropractic – combined with an exercise program offers effective treatment for those suffering from back pain.

29 Nov 2004

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

Forest Laboratories have announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII), the first and only fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg), was approved by the U.S. Food and Drug Administration (FDA) for the short-term management of acute, moderate to severe pain.

29 Nov 2004

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.

24 Nov 2004

Biomedical engineering project creates eyes that will never tire

A pair of eyes that follow you around the room is normally the hallmark of a successful portraitist. Tim Nelson, however, is working to achieve a similar effect by employing a pair of disembodied, robotic eyes.

24 Nov 2004

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

Topical cream alternative to Vioxx

A clinical study recently published in The Journal of Rheumatology concludes that a topical cream consisting of a blend of natural oils called cetylated fatty acids significantly increased range of motion and physical performance in patients with osteoarthritis of the knee with no reported side effects.

24 Nov 2004

Revolutionary new procedure an alternative to spinal fusion

With the FDA's recent approval of an artificial disc that makes spinal fusion "a thing of the past," one nationally renowned spine surgeon is receiving a flood of phone calls from patients interested in seeking relief from chronic back pain.

24 Nov 2004

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

Current guidelines recommend the use of oral NSAIDs in the treatment of knee osteoarthritis and they are used regularly by half of all patients with painful osteoarthritis.

23 Nov 2004

Information about serious adverse effects of cerivastatin were known within months after drug launched

A review of the published literature and of internal company documents from the manufacturer of cerivastatin, a cholesterol lowering drug removed from the market in 2001, suggests that information about serious adverse effects of this medication was known to the company within months after this drug was launched

23 Nov 2004

Pain News and Research

Latest Pain News and Research

Children with sickle cell disease who are at risk for a stroke need ongoing blood transfusions to reduce their risk

Single dose phase I data on CG53135 for the prevention of oral mucositis

Botox may reduce the incidence of keloids, improving the appearance of scars

Pfizer submits regulatory filings for Revatio (sildenafil citrate) as a treatment for pulmonary arterial hypertension

A decade of neglect has weakened UNICEF and threatened the future of child survival

Method for healing spinal injuries in dogs offers hope for preventing human paralysis

New method measures emotional quality of daily experience

$3 million to research whether stress-management techniques can improve immune system responses in women with breast cancer

Potential vaccine for the deadly toxin ricin

African-Americans and the poor with work-related back injuries clearly fare worse

Botox reduces pain and spasms during breast reconstruction after mastectomy

Spinal manipulation combined with exercise program offers effective treatment for back pain

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

Biomedical engineering project creates eyes that will never tire

FDA approval of Tysabri, for the treatment of multiple sclerosis

Topical cream alternative to Vioxx

Revolutionary new procedure an alternative to spinal fusion

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

Information about serious adverse effects of cerivastatin were known within months after drug launched

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pain News and Research

Latest Pain News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in